Genetic association of glycemic traits and antihyperglycemic agent target genes with the risk of lung cancer: A Mendelian randomization study

This publication has 43 references indexed in Scilit:

• Association of Metabolic Syndrome With Risk of Lung Cancer
  Chest, 2023
• Associations of genetically determined lipid traits and lipid-modifying agents with the risk of diabetic retinopathy: A Mendelian randomization study
  Atherosclerosis, 2023
• The AMPK-HOXB9-KRAS axis regulates lung adenocarcinoma growth in response to cellular energy alterations
  Cell Reports, 2022
• Association of BMI With Benefit of Metformin Plus Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors in Patients With Advanced Lung Adenocarcinoma
  JAMA Oncology, 2022
• Ageing-related markers and risks of cancer and cardiovascular disease: a prospective study in the EPIC-Heidelberg cohort
  European Journal of Epidemiology, 2021
• Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization
  JAMA, 2021
• Diabetes, Metformin, and Lung Cancer: Retrospective Study of the Korean NHIS-HEALS Database
  Clinical Lung Cancer, 2020
• The Associations of Aspirin, Statins, and Metformin With Lung Cancer Risk and Related Mortality: A Time-Dependent Analysis of Population-Based Nationally Representative Data
  Journal of Thoracic Oncology, 2020
• Repurposing metformin for the prevention of cancer and cancer recurrence
  Diabetologia, 2017
• The mechanisms of action of metformin
  Diabetologia, 2017